QSAM Biosciences

QSAM Biosciences

Treating cancer in children and adults with targeted radiotherapeutics.

Launch date
Employees
Market cap
€33.5m
Enterprise valuation
€33m (Public information from May 2024)
Austin Texas (HQ)
Authorizing premium user...